Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Preece

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Emerging Topics in Life Sciences|February 1, 2021
Emerging CRISPR/Cas9 applications for T-cell gene editingRoland Preece, Christos Georgiadis
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2025
Clinical development of allogeneic chimeric antigen receptor αβ-T cellsChristos Georgiadis, Roland Preece, Waseem Qasim
JCI Insight|July 13, 2018
TCRαβ/CD3 disruption enables CD3-specific antileukemic T cell immunotherapyJane Rasaiyaah, Christos Georgiadis, Roland Preece, et al.
Gene Therapy|March 24, 2020
'Mini' U6 Pol III promoter exhibits nucleosome redundancy and supports multiplexed coupling of CRISPR/Cas9 effectsRoland Preece, Christos Georgiadis, Soragia Athina Gkazi, et al.
Leukemia|May 26, 2021
Base-edited CAR T cells for combinational therapy against T cell malignanciesChristos Georgiadis, Jane Rasaiyaah, Soragia Athina Gkazi, et al.
Haematologica|December 24, 2025
Allo-defensive, multiplex base-edited, anti-CD38 CAR T cells for 'off-the-shelf' immunotherapyRoland Preece, Oliver Gough, Akshay Joshi, et al.
Leukemia|October 1, 2025
Base edited "universal" donor CAR T-cell strategies for acute myeloid leukaemiaRenuka Kadirkamanathan, Christos Georgiadis, Arnold Kloos, et al.
Molecular Therapy. Methods & Clinical Development|October 26, 2020
CRISPR-Mediated Base Conversion Allows Discriminatory Depletion of Endogenous T Cell Receptors for Enhanced Synthetic ImmunityRoland Preece, Andrea Pavesi, Soragia Athina Gkazi, et al.
Haematologica|July 11, 2024
Umbilical cord blood T cells can be isolated and enriched by CD62L selection for use in 'off the shelf' chimeric antigen receptor T-cell therapies to widen transplant optionsChristos Georgiadis, Lauren Nickolay, Farhatullah Syed, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2018
Long Terminal Repeat CRISPR-CAR-Coupled "Universal" T Cells Mediate Potent Anti-leukemic EffectsChristos Georgiadis, Roland Preece, Lauren Nickolay, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Emerging Topics in Life Sciences|February 1, 2021
Emerging CRISPR/Cas9 applications for T-cell gene editingRoland Preece, Christos Georgiadis
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2025
Clinical development of allogeneic chimeric antigen receptor αβ-T cellsChristos Georgiadis, Roland Preece, Waseem Qasim
JCI Insight|July 13, 2018
TCRαβ/CD3 disruption enables CD3-specific antileukemic T cell immunotherapyJane Rasaiyaah, Christos Georgiadis, Roland Preece, et al.
Gene Therapy|March 24, 2020
'Mini' U6 Pol III promoter exhibits nucleosome redundancy and supports multiplexed coupling of CRISPR/Cas9 effectsRoland Preece, Christos Georgiadis, Soragia Athina Gkazi, et al.
Leukemia|May 26, 2021
Base-edited CAR T cells for combinational therapy against T cell malignanciesChristos Georgiadis, Jane Rasaiyaah, Soragia Athina Gkazi, et al.
Haematologica|December 24, 2025
Allo-defensive, multiplex base-edited, anti-CD38 CAR T cells for 'off-the-shelf' immunotherapyRoland Preece, Oliver Gough, Akshay Joshi, et al.
Leukemia|October 1, 2025
Base edited "universal" donor CAR T-cell strategies for acute myeloid leukaemiaRenuka Kadirkamanathan, Christos Georgiadis, Arnold Kloos, et al.
Molecular Therapy. Methods & Clinical Development|October 26, 2020
CRISPR-Mediated Base Conversion Allows Discriminatory Depletion of Endogenous T Cell Receptors for Enhanced Synthetic ImmunityRoland Preece, Andrea Pavesi, Soragia Athina Gkazi, et al.
Haematologica|July 11, 2024
Umbilical cord blood T cells can be isolated and enriched by CD62L selection for use in 'off the shelf' chimeric antigen receptor T-cell therapies to widen transplant optionsChristos Georgiadis, Lauren Nickolay, Farhatullah Syed, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2018
Long Terminal Repeat CRISPR-CAR-Coupled "Universal" T Cells Mediate Potent Anti-leukemic EffectsChristos Georgiadis, Roland Preece, Lauren Nickolay, et al.
Pageof 2